How to report toxicity associated with targeted therapies?
Author:
Funder
ITMO Cancer
IReSP-2012
French Cancer Plan
CAPTOR academic project
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/27/8/1633/16701580/mdw218.pdf
Reference26 articles.
1. Clinical cancer advances 2015: annual report on progress against cancer from the American Society of Clinical Oncology;Masters;J Clin Oncol,2015
2. Immune checkpoint blockade in cancer therapy;Postow;J Clin Oncol,2015
3. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab;Topalian;J Clin Oncol,2014
4. Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients;Griffioen;Clin Cancer Res,2012
5. Evidence and clinical relevance of tumor flare in patients who discontinue tyrosine kinase inhibitors for treatment of metastatic renal cell carcinoma;Iacovelli;Eur Urol,2015
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Critical gaps in understanding treatment outcomes in adolescents and young adults with lymphoma: A review of current data;eJHaem;2023-08-25
2. Using recurrent time‐to‐event models with multinomial outcomes to generate toxicity profiles;Pharmaceutical Statistics;2021-03-17
3. Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma;Journal of Clinical Oncology;2020-10-20
4. The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma;Gynecologic Oncology;2020-10
5. Understanding Health-Related Quality of Life in Patients with Mantle Cell Lymphoma;Hematology/Oncology Clinics of North America;2020-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3